glp-1 obesity drug news updates The next phase of the race New weight-loss drugs surge in
Description
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective anti-glycemic and weight-loss medications with a strong safety record
Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.
Why the first non-peptide oral GLP-1 is drawing serious attentionand where caution still applies
While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss and healthy eating.
Analysis of nearly 8,000 adults found 45% keep the weight off after one year
